Pharmchem Stock Market Value

PCHM Stock  USD 3.05  0.00  0.00%   
PharmChem's market value is the price at which a share of PharmChem trades on a public exchange. It measures the collective expectations of PharmChem investors about its performance. PharmChem is selling at 3.05 as of the 23rd of December 2024; that is No Change since the beginning of the trading day. The stock's lowest day price was 3.05.
With this module, you can estimate the performance of a buy and hold strategy of PharmChem and determine expected loss or profit from investing in PharmChem over a given investment horizon. Check out PharmChem Correlation, PharmChem Volatility and PharmChem Alpha and Beta module to complement your research on PharmChem.
Symbol

Please note, there is a significant difference between PharmChem's value and its price as these two are different measures arrived at by different means. Investors typically determine if PharmChem is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PharmChem's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

PharmChem 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to PharmChem's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of PharmChem.
0.00
06/26/2024
No Change 0.00  0.0 
In 5 months and 30 days
12/23/2024
0.00
If you would invest  0.00  in PharmChem on June 26, 2024 and sell it all today you would earn a total of 0.00 from holding PharmChem or generate 0.0% return on investment in PharmChem over 180 days. PharmChem is related to or competes with Mesabi Trust, Nutanix, Morningstar Unconstrained, Thrivent High, Via Renewables, T Rowe, and 70082LAB3. PharmChem, Inc. provides PharmChek Sweat Patch that is used to detect drugs of abuse More

PharmChem Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure PharmChem's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess PharmChem upside and downside potential and time the market with a certain degree of confidence.

PharmChem Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for PharmChem's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as PharmChem's standard deviation. In reality, there are many statistical measures that can use PharmChem historical prices to predict the future PharmChem's volatility.
Hype
Prediction
LowEstimatedHigh
0.743.055.36
Details
Intrinsic
Valuation
LowRealHigh
0.402.715.02
Details
Naive
Forecast
LowNextHigh
0.713.015.32
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
3.023.083.13
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as PharmChem. Your research has to be compared to or analyzed against PharmChem's peers to derive any actionable benefits. When done correctly, PharmChem's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in PharmChem.

PharmChem Backtested Returns

PharmChem maintains Sharpe Ratio (i.e., Efficiency) of -0.0572, which implies the firm had a -0.0572% return per unit of risk over the last 3 months. PharmChem exposes eighteen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check PharmChem's Variance of 8.58, risk adjusted performance of (0.05), and Coefficient Of Variation of (1,356) to confirm the risk estimate we provide. The company holds a Beta of -0.55, which implies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning PharmChem are expected to decrease at a much lower rate. During the bear market, PharmChem is likely to outperform the market. At this point, PharmChem has a negative expected return of -0.13%. Please make sure to check PharmChem's variance, as well as the relationship between the value at risk and rate of daily change , to decide if PharmChem performance from the past will be repeated at some point in the near future.

Auto-correlation

    
  -0.26  

Weak reverse predictability

PharmChem has weak reverse predictability. Overlapping area represents the amount of predictability between PharmChem time series from 26th of June 2024 to 24th of September 2024 and 24th of September 2024 to 23rd of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of PharmChem price movement. The serial correlation of -0.26 indicates that nearly 26.0% of current PharmChem price fluctuation can be explain by its past prices.
Correlation Coefficient-0.26
Spearman Rank Test-0.19
Residual Average0.0
Price Variance0.05

PharmChem lagged returns against current returns

Autocorrelation, which is PharmChem pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting PharmChem's pink sheet expected returns. We can calculate the autocorrelation of PharmChem returns to help us make a trade decision. For example, suppose you find that PharmChem has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

PharmChem regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If PharmChem pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if PharmChem pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in PharmChem pink sheet over time.
   Current vs Lagged Prices   
       Timeline  

PharmChem Lagged Returns

When evaluating PharmChem's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of PharmChem pink sheet have on its future price. PharmChem autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, PharmChem autocorrelation shows the relationship between PharmChem pink sheet current value and its past values and can show if there is a momentum factor associated with investing in PharmChem.
   Regressed Prices   
       Timeline  

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

Other Information on Investing in PharmChem Pink Sheet

PharmChem financial ratios help investors to determine whether PharmChem Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in PharmChem with respect to the benefits of owning PharmChem security.